nasal turbinate reduction Turbinate surgery
Conditions
Interventions
At the end of the procedure for turbinate surgery, the control group will
receive the standard treatment of non-absorbable Merocel® nasal packing,
whereas the intervention group will be treated with
Sponsors
Medisch Centrum Leeuwarden
Eligibility
Age
16 Years to 99 Years
Inclusion criteria
Inclusion criteria: 1. Adult patients aged >= 16 years 2. Scheduled for bilateral inferior turbinate surgery, with or without nasal septal surgery 3. Written informed consent
Exclusion criteria
Exclusion criteria: 1. Turbinate surgery combined with rhinoplasty and/or endoscopic sinus surgery 2. Nasal polyps 3. Use of anticoagulants 4. Pregnancy
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The aim of this study is to measure the amount of patient discomfort following turbinate surgery in the intervention group, treated with Arista* AH, compared to the control group, treated with non-absorbable Merocel® nasal packing. This will be measured by means of the Nasal Obstruction Symptom Evaluation (NOSE) scale and four questions on a Visual Analogue Scale (VAS). | — |
Secondary
| Measure | Time frame |
|---|---|
| The secondary aim of this study is to investigate the effects of Arista* AH on preventing excessive postoperative nasal bleeding, by calculating the percentage of excessive postoperative bleedings in the intervention group treated with Arista* AH versus the control group treated with non-absorbable Merocel® nasal packing. | — |
Countries
Netherlands
Outcome results
None listed